Calpain expression varies among different rat and bovine central nervous system regions

Journal of Neuroscience Research

Volumn 53, Issue 4, 1998, Pages 482-489

  Shields, Donald C ^a   Ray, Swapan K ^a   Gantt Wilford, Gloria ^a   Banik, Naren L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Calpain; Calpastatin; Central nervous system; Transcriptional expression; Translational expression

Indexed keywords

CALPAIN; CALPASTATIN; MESSENGER RNA;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN STEM; CATTLE; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; WHITE MATTER;

ANIMALS; BRAIN; BRAIN STEM; CALCIUM-BINDING PROTEINS; CALPAIN; CATTLE; ENZYME PRECURSORS; GENE EXPRESSION REGULATION; ORGAN SPECIFICITY; PROTEIN BIOSYNTHESIS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPINAL CORD; TRANSCRIPTION, GENETIC;

EID: 0031926757     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19980815)53:4<482::AID-JNR10>3.0.CO;2-4     Document Type: Article

References (48)

1. 2+-activated neutral protease (μCANP) deduced from its cDNA sequence. FEBS Lett 205:313-317.
2. Banay-Schwartz M, Deguzman T, Palkovits M, Lajtha A (1994): Calpain activity in adult and aged human brain regions. Neurochem Res 19:563-567.
3. Banik NL, Chakrabarti AK, Hogan EL (1990): Purification of an endogenous 68 kD inhibitor of calcium-activated neutral proteinase (CANP) from bovine brain: Immunoblot identification and characterization. J Neurosci Res 25:119-124.
4. Banik NL, Chakrabarti AK, Hogan EL (1992): Role of calcium-activated neutral proteinase in myelin: Its role and function. In Martenson R (ed): "Myelin, Biology and Chemistry." Caldwell, NJ: Telford Press, pp 571-597.
5. Banik NL, Shields DC, Ray S, Gantt-Wilford G, Hogan EL (1997a): Calpain gene expression in rat CNS regions (abstract). FASEB J 11:A1226.
6. Banik NL, Matzelle DC, Wilford GG, Osborne A, Hogan EL (1997b): Increased calpain content and progressive degradation of neurofilament protein in spinal cord injury. Brain Res 752:301-306.
7. Bartus R (1997): The calpain hypothesis of neurodegeneration: Evidence for a common cytotoxic pathway. Neuroscientist 3:314-327.
8. Bartus R, Heyward NJ, Elliott PJ, Sawyer SD, Dean RL, Akiyuama A, Straub JA, Harbeson SL, Li Z (1995): Calpain inhibitor AK295 protects neurons from focal brain ischemia; effects of post-occlusion intra-arterial administration. Stroke 25:2265-2270.
9. Baudry M, Dubrin R, Lynch G (1987): Subcellular compartmentalization of calcium-dependent and calcium-independent neutral proteases in brain. Synapse 1:506-511.
10. Burgoyne RB, Gumming R (1983): Calcium-dependent proteolysis of microtubule-associated proteins in brain and synaptosomal cytosol. Biochem Soc Trans 11:158-159.
11. Chakrabarti AK, Banik NL, Powers JM, Hogan EL (1989): The regional and subcellular distribution of calcium-activated neutral proteinase (CANP) in the bovine central nervous system. Neurochem Res 14:259-266.
12. Chakrabarti AK, Banik NL, Lobo DC, Terry EC, Hogan EL (1993): Calcium-activated neutral proteinase (calpain) in rat brain during development: Compartmentation and role in myelination. Dev Brain Res 71:107-113.
13. Croall DE, DeMaitino GN (1990): Regulation of calcium-dependent protease activity in vitro: Clues for determining their physiological functions. In Mellgren RL, Murachi T (eds): "Intracellular Calcium-Dependent Proteolysis." Boca Raton, FL: CRC Press, pp 103-114.
14. 2+ activated protease possibly involved in myofibrillar turnover. Biochemistry 15:2159-2167.
15. De Tullio R, Sparatore B, Salamino F, Melloni E, Pontremoli S (1998): Rat brain contains multiple mRNAs for calpastatin. FEBS Lett 422:113-117.
16. Fukuda T, Adachi E, Kawashima S, Yoshiya I, Hashimoto PH (1990): Immunohistochemical distribution of calcium-activated neutral proteinases and endogenous CANP inhibitor in the rabbit hippocampus. J Comp Neurol 302:100-109.
17. Goto K, Iwamoto T, Kondo H (1994): Localization of mRNAs for calpain and calpastatin in the adult rat brain by in situ hybridization histochemistry. Mol, Brain Res 23:40-46.
18. Hamakubo T, Kannagi R, Murachi T, Matus A (1986): Distribution of calpains I and II in rat brain. J Neurosci 6:3103-3111.
19. 2+-activated neutral protease. Biochemistry 27:8122-8128.
20. Ishida S, Emori Y, Suzuki K (1991): Rat calpastatin has diverged primary sequence from other mammalian calpastatins but retains functionally important sequences. Biochim Biophys Acta 1088:436-438.
21. Iwamoto N, Thangnipon W, Crawford C, Emson PC (1991): Localization of calpain immunoreactivity in senile plaques and in neurons undergoing neurofibrillary degeneration in Alzheimer's disease. Brain Res 561:177-180.
22. Kamakura K, Ishiura S, Imajoh S, Nagata N, Sugita H (1992): Distribution of calcium-activated neutral proteinase inhibitor in the central nervous system of the rat. J Neurochem Res 31:543-548.
23. 2+-activated neutral proteinase and effect of extraction of myelin on enzyme activity. Neurochem Int 14:11-15.
24. Laemmli UK (1970): Cleavage of structural proteins during the assembly of the head of bacteriophage T. Nature 227:680-685.
25. Lee WJ, Ma H, Takano E, Yang HQ, Hatanaka M, Maki M (1992): Molecular diversity in amino-terminal domains of human calpastatin by exon skipping, J Biol Chem 267:8437-8442.
26. Li J, Grynspan F, Berman S, Nixon R, Bursztajn S (1996): Regional differences in gene expression for calcium activated neutral proteinases (calpains) and their endogenous inhibitor calpastatin in mouse brain and spinal cord. J Neurobiol 30:171-191.
27. Li ZH, Banik NL (1995): The localization of mcalpain in myelin: Immunocytochemical evidence in different areas of rat brain and nerves. Brain Res 697:112-121.
28. Li ZH, Hogan EL, Banik NL (1995): Role of calpain in spinal cord injury: Increased mcalpain immunoreactivity in spinal cord after compression injury in the rat. Neurochem Int 27:425-432.
29. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951): Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
30. Maki M, Bagci H, Hamaguchi K, Ueda M, Murachi T, Hatanaka M (1989): Inhibition of caipain by a synthetic oligopeptide corresponding to an exon of the human calpastatin gene. J Biol Chem 264:18866-18869.
31. Mellgren RL (1987): Calcium-dependent proteases: An enzyme system active at cellular membranes. FASEBJ 1:110-115.
32. Nakajima-Ijima S, Hamada H, Reddy P, Kakunaga T (1985): Molecular structure of the human cytoplasmic β-actin gene: Interspecies homology of sequences in the introns. Proc Natl Acad Sci USA 82:6133-6137.
33. 2+-activated neutral proteinase specific for the intermediate filament proteins, vimentin and desmin. J Biol Chem 257:5544-5553.
34. Nishimura T, Goll DE (1991): Binding of calpain fragments to calpastatin. J Biol Chem 266:11842-11850.
35. Nixon RA, Saito KI, Grynspan F, Griffin W, Katayama S, Honda T, Mohan P, Shea T, Beermann M (1994): Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease. Ann NY Acad Sci 747:77-91.
36. Onizuka K, Kunimatsu M, Ozaki Y, Muramatsu K, Sasaki M, Nishino H (1995): Distribution of μcalpain proenzyme in the brain and other neural tissues in the rat. Brain Res 697:179-186.
37. Perlmutter LS, Gall C, Baudry M, Lynch G (1990): Distribution of calcium-activated protease calpain in the rat brain. J Comp Neurol 296:269-276.
38. Sakai K, Akanuma H, Imahori K, Kawashima S (1987): A unique specificity of a calcium activated neutral protease indicated in histone hydrolysis. J Biochem 101:911-918.
39. Schlaepfer WW, Zimmerman UJP (1990): The degradation of neurofilaments by calpains. In Mellgren RL, Murachi T (eds): "Intracellular Calcium-Dependent Proteolysis." Boca Raton, FL: CRC Press, pp 241-250.
40. Shields DC, Deibler GE, Banik NL (1997): Calpain, a mediator of myelin breakdown in demyelinating diseases. Ann NY Acad Sci 825:128-130.
41. Shields DC, Tyor WR, Deibler GE, Banik NL (1998): Increased calpain expression in experimental demyelinating optic neuritis: An immunocytochemical study. Brain Res 784:299-304.
42. Siman R, Gall C, Perlmutter LS, Christian C, Baudry M, Lynch G (1985): Distribution of calpain I, an enzyme associated with degenerative activity, in rat brain. Brain Res 347:399-403.
43. Springer JE, Azbill RD, Kennedy SE, George J, Geddes JW (1997): Rapid calpain I activation and cytoskeletal protein degradation following traumatic spinal cord injury: Attenuation with riluzole pretreatment. J Neurochem 69:1592-1600.
44. 2+ ions. J Biochem 90:275-278.
45. Suzuki K, Sorimachi H, Yoshizawa T, Kinbara K, Ishiura S (1995): Calpain: Novel family members, activation, and physiological function. Biol Chem 376:523-529.
46. Takano E, Ueda M, Tsunekawa S, Murakami T, Maki M, Hatanaka M, Murachi T (1991): Molecular diversity of erythrocyte calpastatin. Biomed Biochem Acta 50:517-521.
47. Towbin H, Stachlin T, Gordon J (1979): Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354.
48. Tsubata T, Takahashi K (1989): Limited proteolysis of bovine myelin basic protein by calcium-dependent proteinase form bovine spinal cord. J Biochem 105:23-28.